MENU
+Compare
STIM
Stock ticker: NASDAQ
AS OF
Jan 14, 04:59 PM (EDT)
Price
$1.78
Change
-$0.02 (-1.11%)
Capitalization
123.27M

STIM Neuronetics Forecast, Technical & Fundamental Analysis

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders... Show more

STIM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STIM with price predictions
Jan 13, 2026

STIM in upward trend: price rose above 50-day moving average on January 07, 2026

STIM moved above its 50-day moving average on January 07, 2026 date and that indicates a change from a downward trend to an upward trend. In of 23 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 06, 2026. You may want to consider a long position or call options on STIM as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for STIM crossed bullishly above the 50-day moving average on January 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where STIM advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for STIM moved out of overbought territory on January 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STIM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

STIM broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.507) is normal, around the industry mean (62.991). P/E Ratio (0.000) is within average values for comparable stocks, (38.209). STIM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.662). STIM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.804) is also within normal values, averaging (39.712).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. STIM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STIM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
STIM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STIM is expected to report earnings to fall 29.08% to -9 cents per share on March 10

Neuronetics STIM Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Est.
$-0.13
Q2'25
Missed
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.09
The last earnings report on November 04 showed earnings per share of -12 cents, meeting the estimate of -12 cents. With 326.22K shares outstanding, the current market capitalization sits at 123.27M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive therapies for psychiatric and neurological disorders

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3222 Phoenixville Pike
Phone
+1 610 640-4202
Employees
203
Web
https://www.neurostar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTMEF41.95N/A
N/A
Globe Telecom, Inc.
PGNN12.25N/A
N/A
Paragon Financial Solutions, Inc. (TN)
IDTVF41.90N/A
N/A
Industrivarden AB
RZSMF1.17-0.02
-2.08%
Rizzoli Corriere della Sera Mediagroup SPA AZ
ABCFF0.02N/A
-5.56%
Abacus Mining & Exploration Corp.

STIM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STIM has been loosely correlated with TMCI. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if STIM jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-9.09%
TMCI - STIM
36%
Loosely correlated
-3.21%
MASI - STIM
35%
Loosely correlated
-1.82%
DCTH - STIM
33%
Poorly correlated
+1.26%
ARAY - STIM
32%
Poorly correlated
-1.19%
DIZTF - STIM
31%
Poorly correlated
N/A
More

Groups containing STIM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-9.09%
Health Services
category (412 stocks)
1%
Poorly correlated
-0.23%
Medical/Nursing Services
category (220 stocks)
-1%
Poorly correlated
-0.32%